James W. Cooper

4.4k total citations · 1 hit paper
43 papers, 2.7k citations indexed

About

James W. Cooper is a scholar working on Geriatrics and Gerontology, Pharmacology and Plant Science. According to data from OpenAlex, James W. Cooper has authored 43 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Geriatrics and Gerontology, 7 papers in Pharmacology and 5 papers in Plant Science. Recurrent topics in James W. Cooper's work include Pharmaceutical Practices and Patient Outcomes (23 papers), Pharmacy and Medical Practices (7 papers) and Legume Nitrogen Fixing Symbiosis (5 papers). James W. Cooper is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (23 papers), Pharmacy and Medical Practices (7 papers) and Legume Nitrogen Fixing Symbiosis (5 papers). James W. Cooper collaborates with scholars based in United States, United Kingdom and South Africa. James W. Cooper's co-authors include William E. Wade, Donna M. Fick, J. Ross Maclean, Jennifer L. Waller, Mark H. Beers, Ronald B. Stewart, K. Kunert, Christine H. Foyer, Peter A. Schwartz and C. T. Rhodes and has published in prestigious journals such as Journal of Experimental Botany, Journal of the American Geriatrics Society and Plant Cell & Environment.

In The Last Decade

James W. Cooper

38 papers receiving 2.5k citations

Hit Papers

Updating the Beers Criteria for Potentially Inappropriate... 2003 2026 2010 2018 2003 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James W. Cooper United States 16 1.8k 769 457 391 383 43 2.7k
Petra Thürmann Germany 27 1.4k 0.8× 706 0.9× 515 1.1× 490 1.3× 562 1.5× 161 3.2k
Martin Schulz Germany 31 957 0.5× 341 0.4× 548 1.2× 537 1.4× 538 1.4× 155 4.1k
Katja Taxis Netherlands 32 1.5k 0.9× 481 0.6× 353 0.8× 375 1.0× 421 1.1× 192 3.6k
Maribeth C. Lovegrove United States 20 1.1k 0.6× 461 0.6× 285 0.6× 585 1.5× 459 1.2× 38 3.4k
David O’Sullivan Ireland 17 2.1k 1.2× 1.1k 1.4× 626 1.4× 460 1.2× 372 1.0× 37 2.9k
Koen Boussery Belgium 27 694 0.4× 352 0.5× 406 0.9× 304 0.8× 362 0.9× 142 2.7k
Amy Page Australia 19 2.0k 1.1× 1.1k 1.5× 526 1.2× 411 1.1× 329 0.9× 101 2.7k
Robert J. Cipolle United States 25 1.6k 0.9× 439 0.6× 573 1.3× 304 0.8× 662 1.7× 65 3.6k
Andrew L. Gilbert Australia 32 1.3k 0.7× 708 0.9× 353 0.8× 403 1.0× 410 1.1× 94 3.0k
Emily Hajjar United States 16 2.4k 1.4× 1.2k 1.6× 751 1.6× 682 1.7× 449 1.2× 29 3.5k

Countries citing papers authored by James W. Cooper

Since Specialization
Citations

This map shows the geographic impact of James W. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Cooper more than expected).

Fields of papers citing papers by James W. Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Cooper. The network helps show where James W. Cooper may publish in the future.

Co-authorship network of co-authors of James W. Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Cooper. A scholar is included among the top collaborators of James W. Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Cooper. James W. Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, James W., Michael Wilson, Martijn F. L. Derks, et al.. (2017). Enhancing faba bean (Vicia faba L.) genome resources. Journal of Experimental Botany. 68(8). 1941–1953. 33 indexed citations
2.
Márquez‐García, Belén, James W. Cooper, Barbara Karpińska, et al.. (2015). Redox markers for drought-induced nodule senescence, a process occurring after drought-induced senescence of the lowest leaves in soybean (Glycine max). Annals of Botany. 116(4). 497–510. 47 indexed citations
4.
Cooper, James W., et al.. (2010). Assessment and management of chronic pain in the older adult. Journal of the American Pharmacists Association. 50(3). e89–e102. 9 indexed citations
5.
Cooper, James W., et al.. (2007). Psychotropic and psychoactive drugs and hospitalization rates in nursing facility residents. Pharmacy Practice. 5(3). 140–4. 10 indexed citations
6.
Cooper, James W., et al.. (2006). A Senior Care Clerkship for Pharmacy Students. The Consultant Pharmacist. 21(6). 482–492. 4 indexed citations
7.
Cooper, James W. & William E. Wade. (2005). Pharmacist Interventions in Geriatric Nursing Facility NSAID Therapy: A One-Year Follow-up Study of Costs and Outcomes. The Consultant Pharmacist. 20(6). 492–497. 6 indexed citations
8.
Fick, Donna M., James W. Cooper, William E. Wade, et al.. (2003). Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Archives of Internal Medicine. 163(22). 2716–2716. 1839 indexed citations breakdown →
9.
Cooper, James W.. (2002). Beta-blockers are poorly tolerated by the elderly: myth or reality?. PubMed. 112(6 Suppl Heart). 12–20.
10.
Cooper, James W., et al.. (1998). An Integrated Infectious Disease Course For An Entry-Level Doctor of Pharmacy Curriculum. American Journal of Pharmaceutical Education. 62(3). 296–301. 3 indexed citations
11.
Stewart, Ronald B. & James W. Cooper. (1994). Polypharmacy in the Aged. Drugs & Aging. 4(6). 449–461. 124 indexed citations
12.
Mallet, Louise & James W. Cooper. (1991). Prolongation of Prothrombin Time with the Use of Piroxicam and Warfarin. The Canadian Journal of Hospital Pharmacy. 44(2). 1 indexed citations
13.
Cooper, James W.. (1991). Drug-Related Problems in Geriatric Nursing Home Patients. Medical Entomology and Zoology. 7 indexed citations
14.
Morton, Mark R. & James W. Cooper. (1989). Erythromycin-Induced Digoxin Toxicity. DICP. 23(9). 668–670. 22 indexed citations
16.
Cooper, James W.. (1982). Antihistamines and Decongestants in the Treatment of Chronic Rhinitis. Allergy and Asthma Proceedings. 3(4). 475–479. 3 indexed citations
17.
Cooper, James W., et al.. (1981). The Consultant Pharmacist and Analgesic/Anti‐Inflammatory Drug Usage in a Geriatric Long‐Term Facility*. Journal of the American Geriatrics Society. 29(9). 429–432. 7 indexed citations
18.
Schwartz, Peter A., C. T. Rhodes, & James W. Cooper. (1977). Solubility and Ionization Characteristics of Phenytoin. Journal of Pharmaceutical Sciences. 66(7). 994–997. 66 indexed citations
19.
Lewis, Keith P., et al.. (1976). Pharmacist's effect on digoxin usage and toxicity. American Journal of Health-System Pharmacy. 33(12). 1272–1276.
20.
Cooper, James W., et al.. (1975). Community-Hospital Practitioner Consultation. Journal of the American Pharmaceutical Association (1961). 15(9). 484–487.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026